Literature DB >> 24972742

Bone marrow-derived mesenchymal stromal cells improve vascular regeneration and reduce leukocyte-endothelium activation in critical ischemic murine skin in a dose-dependent manner.

Riccardo Schweizer1, Pranitha Kamat1, Dennis Schweizer2, Cyrill Dennler2, Shengye Zhang2, Jonas T Schnider2, Souzan Salemi3, Pietro Giovanoli4, Daniel Eberli3, Volker Enzmann5, Dominique Erni2, Jan A Plock6.   

Abstract

BACKGROUND AIMS: Stem cells participate in vascular regeneration following critical ischemia. However, their angiogenic and remodeling properties, as well as their role in ischemia-related endothelial leukocyte activation, need to be further elucidated. Herein, we investigated the effect of bone marrow-derived mesenchymal stromal cells (BM-MSCs) in a critically ischemic murine skin flap model.
METHODS: Groups received either 1 × 10(5), 5 × 10(5), or 1 × 10(6) BM-MSCs or cell-free conditioned medium (CM). Controls received sodium chloride. Intravital fluorescence microscopy was performed for morphological and quantitative assessment of micro-hemodynamic parameters over 12 days.
RESULTS: Tortuosity and diameter of conduit-arterioles were pronounced in the MSC groups (P < 0.01), whereas vasodilation was shifted to the end arteriolar level in the CM group (P < 0.01). These effects were accompanied by angiopoietin-2 expression. Functional capillary density and red blood cell velocity were enhanced in all treatment groups (P < 0.01). Although a significant reduction of rolling and sticking leukocytes was observed in the MSC groups with a reduction of diameter in postcapillary venules (P < 0.01), animals receiving CM exhibited a leukocyte-endothelium interaction similar to controls. This correlated with leukocyte common antigen expression in tissue sections (P < 0.01) and p38 mitogen-activated protein kinase expression from tissue samples. Cytokine analysis from BM-MSC culture medium revealed a 50% reduction of pro-inflammatory cytokines (interleukin [IL]-1β, IL-6, IL-12, tumor necrosis factor-α, interferon-γ) and chemokines (keratinocyte chemoattractant, granulocyte colony-stimulating factor) under hypoxic conditions. DISCUSSION: We demonstrated positive effects of BM-MSCs on vascular regeneration and modulation of endothelial leukocyte adhesion in critical ischemic skin. The improvements after MSC application were dose-dependent and superior to the use of CM alone.
Copyright © 2014 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  angiogenesis; arteriogenesis; conditioned medium; immunomodulation; mesenchymal stromal cells; paracrine function; vascular regeneration

Mesh:

Year:  2014        PMID: 24972742     DOI: 10.1016/j.jcyt.2014.05.008

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  9 in total

1.  Enhanced survival of ischemic skin flap by combined treatment with bone marrow-derived stem cells and low-level light irradiation.

Authors:  Jeong Hwan Moon; Yun-Hee Rhee; Jin-Chul Ahn; Bongkyun Kim; Sang Joon Lee; Phil-Sang Chung
Journal:  Lasers Med Sci       Date:  2017-08-23       Impact factor: 3.161

2.  Effect of Systemic Adipose-derived Stem Cell Therapy on Functional Nerve Regeneration in a Rodent Model.

Authors:  Riccardo Schweizer; Jonas T Schnider; Paolo M Fanzio; Wakako Tsuji; Nataliya Kostereva; Mario G Solari; Jan A Plock; Vijay S Gorantla
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-07-21

3.  International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.

Authors:  Jacques Galipeau; Mauro Krampera; John Barrett; Francesco Dazzi; Robert J Deans; Joost DeBruijn; Massimo Dominici; Willem E Fibbe; Adrian P Gee; Jeffery M Gimble; Peiman Hematti; Mickey B C Koh; Katarina LeBlanc; Ivan Martin; Ian K McNiece; Michael Mendicino; Steve Oh; Luis Ortiz; Donald G Phinney; Valerie Planat; Yufang Shi; David F Stroncek; Sowmya Viswanathan; Daniel J Weiss; Luc Sensebe
Journal:  Cytotherapy       Date:  2015-12-23       Impact factor: 5.414

Review 4.  Adult vascular wall resident multipotent vascular stem cells, matrix metalloproteinases, and arterial aneurysms.

Authors:  Bruno Amato; Rita Compagna; Maurizio Amato; Raffaele Grande; Lucia Butrico; Alessio Rossi; Agostino Naso; Michele Ruggiero; Stefano de Franciscis; Raffaele Serra
Journal:  Stem Cells Int       Date:  2015-03-18       Impact factor: 5.443

5.  c-Kit-Positive Adipose Tissue-Derived Mesenchymal Stem Cells Promote the Growth and Angiogenesis of Breast Cancer.

Authors:  Wenjie Li; Haiqian Xu; Cheng Qian
Journal:  Biomed Res Int       Date:  2017-05-10       Impact factor: 3.411

6.  Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): a translational approach.

Authors:  Rouven Berndt; Lars Hummitzsch; Katharina Heß; Martin Albrecht; Karina Zitta; Rene Rusch; Beke Sarras; Andreas Bayer; Jochen Cremer; Fred Faendrich; Justus Groß
Journal:  Stem Cell Res Ther       Date:  2018-04-27       Impact factor: 6.832

Review 7.  Therapeutic Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in the Prevention of Organ Injuries Induced by Traumatic Hemorrhagic Shock.

Authors:  Guillaume Valade; Nicolas Libert; Christophe Martinaud; Eric Vicaut; Sébastien Banzet; Juliette Peltzer
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

Review 8.  Endothelial-Leukocyte Interaction in Severe Malaria: Beyond the Brain.

Authors:  Mariana C Souza; Tatiana A Padua; Maria G Henriques
Journal:  Mediators Inflamm       Date:  2015-09-30       Impact factor: 4.711

9.  Cell Based Therapeutic Approach in Vascular Surgery: Application and Review.

Authors:  Aldo Rocca; Domenico Tafuri; Marianna Paccone; Antonio Giuliani; Anna Ginevra Immacolata Zamboli; Giuseppe Surfaro; Andrea Paccone; Rita Compagna; Maurizo Amato; Raffaele Serra; Bruno Amato
Journal:  Open Med (Wars)       Date:  2017-10-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.